Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
An algorithm based testing for Fatty Liver Disease
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
MINYM can be safely used by patients above 9 years of age.
Dr. Reddy's Fesoterodine Fumarate Extended-Release Tablets are available in 4 mg and 8 mg Tablets, each in bottle count sizes of 30.
The addition of Sitaglyn and Siglyn to our diabetes portfolio will give patients access to a world-class oral therapy to help people manage their diabetes
The combined company will be able to better serve both our global and regional customers with local production
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
Subscribe To Our Newsletter & Stay Updated
